Delivery Order SPE2DB20D3104-SPE2DB22FV4P9
- Not listed
- This federal contract award is for the delivery of Escitalopram 10 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $6,951.57, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award is for the delivery of escitalopram 10 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,072.80 and a completion date of February 6, 2023. This is a delivery order contract, with a firm fixed price pricing type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of Escitalopram 20 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $2,695.81. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of December 27, 2023. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- This federal contract award is for the delivery of Escitalopram 20 mg tablets to the Defense Logistics Agency (DLA). The $1,231.94 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on May 17, 2023, with a completion date of May 18, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award is for the delivery of Escitalopram 20 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $5,033.03. The contract is a delivery order with a firm fixed price, and has an ultimate completion date of April 24, 2023. The contract was not set aside for any specific business designation....
- This federal contract award is for the delivery of Escitalopram 10 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $15,380.99 and is a firm fixed-price delivery order, with a completion date of May 2, 2023. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent...
- This federal contract award is for the delivery of Escitalopram 5mg tablets to the Defense Logistics Agency (DLA). The $1,843.79 Firm Fixed Price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has an Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Escitalopram 10 mg tablets. The $2,767.45 firm fixed-price contract has a completion date of September 21, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary vehicle for the company to provide a comprehensive...
- This federal contract award is for the delivery of escitalopram 20 mg tablets to support military healthcare programs. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, with a ceiling value of $14,526.13. It is a delivery order contract with a firm fixed price pricing type and a completion date of February 27, 2024. The...
- This federal contract award is for the delivery of Escitalopram 5 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that is a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price of $11,094.06 and an ultimate completion date of January 12, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB22FV4P9Delivery Order
This federal contract award is for the delivery of Escitalopram 10 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,972.76, is a firm fixed-price delivery order with a completion date of January 26, 2022. The award was made without the use of a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 1/25/22 |